T-cell lymphoma: Difference between revisions
No edit summary |
|||
Line 20: | Line 20: | ||
==[[T-cell lymphoma overview|Overview]]== | ==[[T-cell lymphoma overview|Overview]]== | ||
==[[T-cell lymphoma historical perspective|Historical Perspective]]== | ==[[T-cell lymphoma historical perspective|Historical Perspective]]== |
Revision as of 15:17, 18 January 2012
For patient information click here.
T-cell lymphoma | |
MeSH | D016399 |
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Historical Perspective
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes
Differentiating T-cell lymphoma
Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics
Treatment
Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies
See also